EW vs TOVX · P/E 47, rev $3.39B vs rev $300.0K
Edwards Lifesciences Corp (EW) versus Theriva Biologics Inc. (TOVX) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Theriva Biologics Inc. (TOVX) is a biotechnology company listed on NYSE MKT.
Latest reported EW revenue for 2026-06-30 was $3.39B. Net income was $622.6M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported TOVX revenue for 2026-06-30 was $300.0K. Net income was -$5.3M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. TOVX currently screens at market cap $12.4M.
EW currently screens at market cap $49.91B and trailing P/E 46.9. TOVX currently screens at market cap $12.4M.
Not investment advice. Open the EW and TOVX stock pages for the full models.
Not investment advice.